AMERICAN INTERNATIONAL GROUP, INC. - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 191 filers reported holding IMMUNOVANT INC in Q3 2023. The put-call ratio across all filers is 2.28 and the average weighting 0.6%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$1,033,766
+109.8%
26,928
+3.7%
0.01%
+133.3%
Q2 2023$492,670
+48.1%
25,971
+21.1%
0.00%
+50.0%
Q1 2023$332,752
-10.8%
21,454
+2.0%
0.00%
-33.3%
Q4 2022$373,229
+252.1%
21,027
+10.6%
0.00%
+200.0%
Q3 2022$106,000
+45.2%
19,015
+1.4%
0.00%
Q2 2022$73,000
-34.2%
18,746
-7.0%
0.00%
-100.0%
Q1 2022$111,000
-39.0%
20,147
-5.4%
0.00%0.0%
Q4 2021$182,000
-4.7%
21,305
-2.9%
0.00%0.0%
Q3 2021$191,000
-14.0%
21,942
+4.4%
0.00%0.0%
Q2 2021$222,000
-36.8%
21,021
-3.8%
0.00%0.0%
Q1 2021$351,000
-65.1%
21,853
+0.3%
0.00%
-75.0%
Q4 2020$1,007,000
+37.0%
21,796
+4.4%
0.00%0.0%
Q3 2020$735,000
+157.9%
20,876
+78.6%
0.00%
+300.0%
Q2 2020$285,00011,6880.00%
Other shareholders
IMMUNOVANT INC shareholders Q3 2023
NameSharesValueWeighting ↓
Alpine Global Management, LLC 4,448,017$17,347,0004.39%
Deep Track Capital, LP 9,455,000$36,875,0002.42%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 233$60,000,0000.63%
Octagon Capital Advisors LP 579,061$2,258,0000.60%
Eventide Asset Management 5,372,512$20,953,0000.45%
WITTENBERG INVESTMENT MANAGEMENT, INC. 174,000$679,0000.29%
Frazier Life Sciences Management, L.P. 585,759$2,284,0000.22%
BCK CAPITAL MANAGEMENT LP 54,293$212,0000.16%
PLATINUM INVESTMENT MANAGEMENT LTD 777,590$3,033,0000.12%
Bridgefront Capital, LLC 15,649$61,0000.07%
View complete list of IMMUNOVANT INC shareholders